0001572426-15-000080.txt : 20150716 0001572426-15-000080.hdr.sgml : 20150716 20150716185051 ACCESSION NUMBER: 0001572426-15-000080 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150715 FILED AS OF DATE: 20150716 DATE AS OF CHANGE: 20150716 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nexvet Biopharma plc CENTRAL INDEX KEY: 0001618561 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: NATL INST FOR BIOPROCESSING RESEARCH STREET 2: FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK CO. DUBLIN STATE: L2 ZIP: 00000 BUSINESS PHONE: 353 1 215 8100 MAIL ADDRESS: STREET 1: NATL INST FOR BIOPROCESSING RESEARCH STREET 2: FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK CO. DUBLIN STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd DATE OF NAME CHANGE: 20140903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wald Graeme CENTRAL INDEX KEY: 0001632455 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36828 FILM NUMBER: 15992386 MAIL ADDRESS: STREET 1: C/O NEXVET BIOPHARMA PLC STREET 2: NATL INST, FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK STATE: L2 ZIP: 00000 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-07-15 1 0001618561 Nexvet Biopharma plc NVET 0001632455 Wald Graeme C/O NEXVET BIOPHARMA PLC NIBRT; FOSTERS AVENUE; MOUNT MERRION BLACKROCK L2 IRELAND 1 0 0 0 Ordinary Shares 2015-07-15 4 M 0 3600 .125 A 3600 D Ordinary Shares 6176 I Wald Funds Pty Ltd <Wald Funds Unit A/C> Ordinary Shares 7548 I JanCutz Pty Ltd <Emuna Superannuation Fund A/C> Options to Purchase Shares .125 2015-07-15 4 M 0 3600 0 D 2014-09-30 2019-07-01 Ordinary Shares 3600 0 D The reporting person has sole voting and dispositive power with respect to these reported securities. The option to purchase shares vested and became exercisable as to 25% of the grant on each of 9/30/14, 12/31/14, 3/31/15 and 6/30/15. /s/ Graeme David Wald by Geraldine Farrell, Attorney-in-Fact 2015-07-15